查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2008261

十二指肠内视镜市场：按产品类型、分销管道、最终用户和应用分類的全球市场预测，2026-2032年

Duodenoscopes Market by Product Type, Distribution Channel, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，十二指肠内视镜市场价值将达到 23.8 亿美元，到 2026 年将成长至 25.9 亿美元，到 2032 年将达到 42.5 亿美元，复合年增长率为 8.62%。

主要市场统计数据
基准年 2025 23.8亿美元
预计年份：2026年 25.9亿美元
预测年份 2032 42.5亿美元
复合年增长率 (%) 8.62%

简要概述十二指肠内视镜的临床作用、再处理方面的挑战、感染控制的重要性、技术进步以及影响近期器材策略的相关人员趋势。

十二指肠镜在高级内视镜手术中发挥着至关重要的作用，它能够实现诸如内视镜逆行造影（ERCP）等诊断和治疗技术，而ERCP对于胆道和胰腺疾病的诊治至关重要。其复杂的结构设计（可实现通道式入路、成像和器械输送）是其临床效用的基础，但也带来了再处理方面的复杂性以及医疗设备相关感染的风险。近年来，引人注目的感染病例和日益严格的监管审查，使得人们对这种医疗设备的关注点从单纯的临床应用转向了病患安全措施、筹资策略和生产品质保证等方面。

对重塑十二指肠内视镜市场的变革性变化进行前瞻性概述，包括一次性产品的引入、设计创新、监管压力和供应链重组。

十二指肠内视镜市场正经历着结构性变革时期，其驱动力来自临床安全要求、技术创新以及采购行为的转变。一次性内视镜的普及正成为一股颠覆性力量，这主要得益于医疗机构对感染控制和工作流程效率的日益重视。同时，可重复使用内视镜的製造商也在加速改进设备设计、材料以及与先进再处理技术的兼容性，以应对灭菌方面的挑战，同时保持可重复使用平台的临床优势。

对美国已实施和提案于 2025 年实施的关税措施如何改变供应链经济、货源选择、製造地和采购行为进行重点分析。

美国2025年的关税决定引入了新的贸易动态，将对十二指肠内视镜及相关耗材的采购、供应商选择和製造地选择产生重大影响。关税调整将影响整个复杂价值链的成本结构，而精密製造、光学技术和特殊聚合物等零件通常依赖国际采购。对于采购者而言，直接影响是多方面的。采购团队必须重新评估其对供应商总到岸成本的假设，评估替代采购区域的可行性，并考虑重新谈判的供应合约对其营运的影响。

精细的细分洞察揭示了产品类型、最终用户、临床应用和分销管道如何对采用、购买和营运实践产生不同的影响。

有效的市场区隔能清楚展现十二指肠内视镜市场整体中，市场接受度压力与商业性机会的差异所在。依产品类型，市场可分为「可重复使用」与「一次性」两大类，其中「可重复使用」类又可细分为「传统型」和「增强型」设计，后者俱备便于再处理和提升诊断能力的特性。这些差异显着影响了采购决策。一次性产品强调降低感染风险和简化物流，而传统型可重复使用产品则着重于单次手术成本和长期使用寿命，增强型可重复使用产品图在这些优先事项的基础上，进一步提升安全性。

美洲、欧洲、中东和非洲以及亚太地区的区域策略趋势和临床应用差异正在影响商业性和监管策略。

医疗设备偏好、监管严格程度和采购方式的地理分布在不同主要地区存在显着差异，从而导致不同的策略应对措施。在美洲，采购往往集中在大规模医疗系统内部，并受到严格的感染控制标准的驱动。这推动了对检验的再处理解决方案以及高风险环境下的替代性一次性使用方案的需求。支付和报销机制也会影响各机构如何权衡对再处理基础设施的投资与采用一次性医疗设备之间的关係。

对领先的医疗设备製造商、服务供应商和经销商如何调整产品系列、伙伴关係和品管系统以确保韧性进行竞争考察和企业趋势洞察。

领先的製造商和服务供应商正从单一产品策略转向整合解决方案，将医疗设备的效能与检验处理、培训和资讯服务相结合。许多公司正在投资进行设计改进，优先考虑可清洗性和与自动化再处理系统的兼容性，同时也在开发配件生态系统和数位化解决方案，以增强可追溯性和用户回馈。医疗设备製造商与灭菌服务供应商和经销商之间的合作日益普遍，从而能够提供捆绑式提案，简化采购流程并降低组织风险。

为製造商、医疗保健提供者和通路合作伙伴提供可操作且优先考虑的建议，以降低风险、优化营运并加速采用安全技术。

产业领导者应优先采取一系列策略干预措施，以降低临床风险并增强商业性韧性。首先，他们应投资于设计和工程改进，以显着提高产品的可清洗性和与自动化再处理系统的兼容性，同时确保配件的兼容性，从而维持临床功能。其次，他们应重组供应链策略，以降低关税衝击和零件短缺的风险。这包括选择替代供应商、评估关键部件的部分在地采购，以及提高与一级和二级供应商关係的透明度。

本报告详细介绍了高度透明的调查方法，包括初步调查、专家检验、医疗设备和监管审查，以及用于得出可靠的定性结果的三角测量方法。

本执行摘要所依据的研究整合了初步访谈、医疗设备技术审查和监管文件分析，建构了一个多方面的证据基础。初步研究包括对临床终端使用者、采购经理、灭菌专家和医疗设备工程师的详细访谈，以了解实际操作、流程限制和采购因素。这些定性研究结果与对医疗设备结构、再处理通讯协定以及已报告的召回和安全资讯的技术评估进行了交叉比对，以确保临床实践与医疗设备的性能特征相符。

最后，本文将重点介绍如何协调临床安全要求与商业策略以及整个生态系统中持续的技术变革，从而实现实际应用。

总而言之，十二指肠内视镜生态系统正面临着病患安全需求、技术创新、监管预期和不断变化的商业性经济等诸多复杂挑战。将医疗设备的选择和供应合约视为综合性的临床和营运决策的相关人员，将更有能力在维持手术能力的同时管理风险。可重复使用设计改进和一次性替代方案这两种路径，都体现了生命週期成本、环境因素和感染预防之间合理的权衡，并且都需要严谨的证据和运营的一致性才能取得成功。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 十二指肠内视镜市场：依产品类型划分

  • 可重复使用的
    • 传统的
    • 增强型
  • 一次性的

第九章 十二指肠内视镜市场：依通路划分

  • 直接地
  • 间接
    • 批发商
    • 零售商

第十章 十二指肠内视镜市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院

第十一章 十二指肠内视镜市场：依应用领域划分

  • 诊断
  • 治疗

第十二章 十二指肠内视镜市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 十二指肠内视镜市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 十二指肠内视镜市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国十二指肠内视镜市场

第十六章：中国十二指肠内视镜市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Ambu A/S
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cantel Medical Corporation
  • CONMED Corporation
  • Cook Medical
  • EndoChoice, Inc.
  • Erbe Elektromedizin GmbH
  • FUJIFILM Holdings Corporation
  • Getinge AB
  • HOYA Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Ottomed Endoscopy
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • SonoScape Medical Corp.
  • STERIS plc
  • Stryker Corporation
  • Teleflex Incorporated
Product Code: MRR-C002B1C99487

The Duodenoscopes Market was valued at USD 2.38 billion in 2025 and is projected to grow to USD 2.59 billion in 2026, with a CAGR of 8.62%, reaching USD 4.25 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.38 billion
Estimated Year [2026] USD 2.59 billion
Forecast Year [2032] USD 4.25 billion
CAGR (%) 8.62%

A concise orientation to duodenoscope clinical role, reprocessing challenges, infection control imperatives, technological evolution, and stakeholder dynamics shaping near-term device strategies

Duodenoscopes occupy a critical role in advanced endoscopy, enabling diagnostic and therapeutic procedures such as endoscopic retrograde cholangiopancreatography (ERCP) that are essential for biliary and pancreatic disease management. Their intricate design, which permits channelized access, imaging, and instrument delivery, underpins clinical utility but simultaneously creates reprocessing complexity and vulnerability to device-associated infections. Over recent years, high-profile infection events and enhanced regulatory scrutiny have elevated the device from a purely clinical asset to a focal point for patient safety initiatives, procurement strategy, and manufacturing quality assurance.

Consequently, stakeholders across clinical, regulatory, and commercial functions are recalibrating priorities. Infection prevention teams demand demonstrable reprocessing validation and traceability, procurement organizations seek total cost and risk transparency, and device manufacturers respond with engineering changes, reprocessing adjuncts, and alternative product models. As a result, the duodenoscope landscape is being reshaped by competing imperatives: maximizing clinical capability while minimizing cross-contamination risk and operational friction. This executive summary synthesizes these dynamics to inform strategic decision making for providers, manufacturers, and channel partners operating in this technically demanding segment.

A forward-looking synthesis of transformative shifts reshaping the duodenoscope landscape including single-use adoption, design innovation, regulatory pressure, and supply chain reconfiguration

The duodenoscope market is experiencing a period of structural transformation driven by a convergence of clinical safety demands, engineering innovation, and shifting procurement behaviors. Single-use device adoption has emerged as a disruptive force, spurred by institutions prioritizing infection avoidance and streamlined workflow. At the same time, manufacturers of reusable scopes are accelerating enhancements in device design, materials, and compatibility with advanced reprocessing technologies to preserve the clinical advantages of reusable platforms while addressing sterilization gaps.

Regulatory agencies and hospital accreditation bodies have tightened expectations for validation, surveillance, and reporting, prompting more rigorous clinical surveillance programs and tighter procurement specifications. Simultaneously, digitalization-ranging from embedded diagnostics to cloud-enabled reprocessing logs-is changing how devices are monitored and how value is communicated to buyers. Supply chain resilience has become a strategic concern, with nearshoring and diversified sourcing increasingly considered to mitigate disruption risk. Together, these shifts are not incremental; they represent a redefinition of acceptable tradeoffs between cost, clinical performance, and patient safety, compelling all ecosystem participants to adopt more transparent, evidence-based approaches to product development and commercialization.

A focused analysis of how recent and proposed United States tariff measures in 2025 are altering supply economics, sourcing choices, manufacturing footprints, and procurement behavior

United States tariff decisions in 2025 introduced new trade dynamics that materially influence procurement, sourcing, and manufacturing choices for duodenoscopes and associated consumables. Tariff adjustments affect cost structures across complex value chains where precision manufacturing, optics, and specialized polymers are often sourced internationally. For buyers, the immediate implications are layered: procurement teams must reassess supplier total landed cost assumptions, evaluate the viability of alternative sourcing geographies, and consider the operational impact of re-negotiated supply agreements.

Manufacturers confronted with higher input costs are reviewing production footprints and may accelerate strategies that reduce exposure to tariff volatility, including component localization, qualification of domestic sub-suppliers, or vertical integration for critical subsystems. These strategic shifts also influence channel economics, as distributors and service providers reconsider inventory strategies and lead times. Regulatory considerations intersect with tariff impacts because changes to manufacturing locations or suppliers frequently necessitate additional validation and documentation. In this environment, stakeholders who proactively map supply dependencies, test alternative sourcing scenarios, and engage in collaborative contracting are better positioned to maintain continuity of care and protect margins without compromising compliance or clinical performance.

Granular segmentation insights revealing how product types, end users, clinical applications, and distribution channels differentially influence adoption, purchasing, and operational practices

Meaningful segmentation clarifies where adoption pressures and commercial opportunities diverge across the duodenoscope landscape. Based on product type, the market is studied across Reusable and Single-Use, with the Reusable category further differentiated into Conventional and Enhanced designs that incorporate reprocessing-friendly features or diagnostic upgrades. These variations drive distinct procurement conversations: single-use models emphasize infection risk mitigation and simplified logistics, whereas conventional reusable products focus on per-procedure economics and long lifecycle performance, and enhanced reusable models attempt to balance those priorities with improved safety features.

Based on end user, the market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals, each with different procedural volumes, sterilization capabilities, and capital allocation constraints that influence device selection and service model preferences. Based on application, the market is studied across Diagnostic and Therapeutic indications, where the need for accessory compatibility, imaging resolution, and torque response can favor particular device formats. Based on distribution channel, the market is studied across Direct and Indirect pathways, with the Indirect route further segmented into Distributor and Retailer relationships that affect inventory strategies, service bundling, and post-sale support. Understanding these intersecting segmentations is essential to tailor product design, pricing, and customer engagement models that align with the operational realities of each buyer cohort.

Regional strategic patterns and clinical adoption differentials across Americas, Europe, Middle East & Africa, and Asia-Pacific that inform commercial and regulatory tactics

Geographic patterns in device preference, regulatory intensity, and procurement modality vary substantially across major regions, shaping distinct strategic responses. In the Americas, procurement tends to be centralized within large health systems and driven by stringent infection control standards, which increases demand for validated reprocessing solutions and alternative single-use options in high-risk settings. Payment and reimbursement mechanisms also influence how organizations weigh capital investment in reprocessing infrastructure against disposable device adoption.

In Europe, Middle East & Africa, heterogeneity in regulatory frameworks and healthcare financing creates a mosaic of adoption behaviors, where higher-resource markets emphasize validated reprocessing and traceability, while other jurisdictions prioritize cost containment and supply availability. Regulatory harmonization efforts and cross-border collaboration are influencing product registration and post-market surveillance approaches. In Asia-Pacific, rapid procedural growth, rising clinical capacity, and diverse manufacturing ecosystems produce both strong demand for cost-effective reusable instruments and opportunities for locally produced single-use alternatives. Regional supply chain strategies, local manufacturing partnerships, and regulatory engagement are therefore critical levers for commercial success across these differentiated markets.

Competitive and corporate insights on how leading device makers, service providers, and distributors are aligning product portfolios, partnerships, and quality systems for resilience

Leading manufacturers and service providers are shifting from single-product strategies toward integrated solutions that combine device performance with validated reprocessing, training, and data services. Many corporations are investing in design changes that prioritize cleanability and compatibility with automated reprocessing equipment while also developing accessory ecosystems and digital offerings that enhance traceability and user feedback. Partnerships between device firms and sterilization service providers or distributors are increasingly common, enabling bundled propositions that simplify procurement and reduce institutional risk.

Commercial differentiation is also emerging through warranty and service models that share risk with customers, such as outcome-linked agreements or comprehensive managed service contracts. Firms that excel in regulatory intelligence, post-market surveillance, and rapid corrective action gain credibility with large health systems that demand transparent evidence of safety and efficacy. Meanwhile, smaller innovators and start-ups are concentrating on niche opportunities, including lower-cost single-use devices or advanced imaging modules, forcing incumbents to balance core portfolio defense with targeted acquisitions or licensing arrangements. Across the ecosystem, the ability to demonstrate validated processes, supply resilience, and measurable clinical benefit is becoming the primary axis of competitive advantage.

Practical, prioritized recommendations for manufacturers, healthcare providers, and channel partners to mitigate risk, optimize operations, and accelerate safe technology adoption

Industry leaders should prioritize a set of strategic interventions that reduce clinical risk and reinforce commercial resilience. First, invest in design and engineering improvements that materially enhance cleanability and compatibility with automated reprocessing systems, while ensuring accessory compatibility to preserve clinical capability. Second, reconfigure supply chain strategies to reduce exposure to tariff shocks and component scarcity; this includes qualifying alternative suppliers, evaluating partial localization for critical components, and increasing transparency in supplier tier-one and tier-two relationships.

Third, adopt outcome-oriented commercial models that align incentives with health system goals, such as managed service contracts that bundle device performance, maintenance, and reprocessing oversight. Fourth, strengthen regulatory and post-market capabilities to accelerate response to safety signals and provide customers with robust evidence packages. Finally, develop targeted engagement programs for distinct buyer segments-ambulatory centers, clinics, and hospitals-tailoring value propositions to procedural volume, sterilization capability, and capital constraints. Implementing these recommendations will require cross-functional coordination but will materially reduce operational risk and create differentiated customer value.

Transparent research methodology detailing primary engagement, expert validation, device and regulatory review, and triangulation methods used to produce robust qualitative insights

The research underpinning this executive summary integrates primary interviews, device technical reviews, and regulatory documentation analysis to construct a multi-source evidence base. Primary engagements included in-depth interviews with clinical end users, procurement leaders, sterilization specialists, and device engineers to capture operational realities, procedural constraints, and procurement drivers. These qualitative insights were triangulated with technical assessments of device construction, reprocessing protocols, and reported device recalls or safety communications to ensure alignment between clinical practice and device performance characteristics.

Regulatory and standards databases were reviewed to map evolving compliance expectations and surveillance requirements. Additionally, supply chain mapping exercises identified key supplier dependencies and potential bottlenecks. Throughout the process, expert validation occurred via panels of clinicians, infection preventionists, and industry practitioners to vet findings and refine practical recommendations. This mixed-methods approach emphasizes reproducibility, transparency, and direct relevance to decision makers seeking evidence-based pathways for procurement, product development, and operational improvement.

Conclusive synthesis emphasizing actionable takeaways that reconcile clinical safety imperatives with commercial strategy and ongoing technology transitions across the ecosystem

In synthesis, the duodenoscope ecosystem is navigating a complex intersection of patient safety imperatives, engineering innovation, regulatory expectations, and shifting commercial economics. Stakeholders who treat device selection and supply contracting as integrated clinical-operational decisions will be better positioned to manage risk while preserving procedural capability. The dual trajectories of enhanced reusable designs and single-use alternatives reflect legitimate tradeoffs between lifecycle cost, environmental considerations, and infection prevention, and both paths require rigorous evidence and operational alignment to succeed.

Strategic responses that combine design improvement, supply chain diversification, and outcome-oriented commercial models provide a pragmatic route to reconciling clinical needs with organizational constraints. Ultimately, the most resilient actors will be those that transparently document performance, maintain agile sourcing strategies, and partner closely with clinical teams to ensure that device choices support both patient safety and sustainable operational models. This report equips decision makers with the contextualized insights needed to navigate these tradeoffs and to implement practical steps that reduce risk and enhance value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Duodenoscopes Market, by Product Type

  • 8.1. Reusable
    • 8.1.1. Conventional
    • 8.1.2. Enhanced
  • 8.2. Single-Use

9. Duodenoscopes Market, by Distribution Channel

  • 9.1. Direct
  • 9.2. Indirect
    • 9.2.1. Distributor
    • 9.2.2. Retailer

10. Duodenoscopes Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Duodenoscopes Market, by Application

  • 11.1. Diagnostic
  • 11.2. Therapeutic

12. Duodenoscopes Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Duodenoscopes Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Duodenoscopes Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Duodenoscopes Market

16. China Duodenoscopes Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ambu A/S
  • 17.6. B. Braun Melsungen AG
  • 17.7. Boston Scientific Corporation
  • 17.8. Cantel Medical Corporation
  • 17.9. CONMED Corporation
  • 17.10. Cook Medical
  • 17.11. EndoChoice, Inc.
  • 17.12. Erbe Elektromedizin GmbH
  • 17.13. FUJIFILM Holdings Corporation
  • 17.14. Getinge AB
  • 17.15. HOYA Corporation
  • 17.16. Intuitive Surgical, Inc.
  • 17.17. Johnson & Johnson Services, Inc.
  • 17.18. KARL STORZ SE & Co. KG
  • 17.19. Medtronic plc
  • 17.20. Olympus Corporation
  • 17.21. Ottomed Endoscopy
  • 17.22. Richard Wolf GmbH
  • 17.23. Smith & Nephew plc
  • 17.24. SonoScape Medical Corp.
  • 17.25. STERIS plc
  • 17.26. Stryker Corporation
  • 17.27. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL DUODENOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DUODENOSCOPES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DUODENOSCOPES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DUODENOSCOPES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DUODENOSCOPES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DUODENOSCOPES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES DUODENOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA DUODENOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DUODENOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DUODENOSCOPES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DUODENOSCOPES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DUODENOSCOPES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DUODENOSCOPES MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DUODENOSCOPES MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DUODENOSCOPES MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DUODENOSCOPES MARKET SIZE, BY ENHANCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DUODENOSCOPES MARKET SIZE, BY ENHANCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DUODENOSCOPES MARKET SIZE, BY ENHANCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DUODENOSCOPES MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DUODENOSCOPES MARKET SIZE, BY SINGLE-USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DUODENOSCOPES MARKET SIZE, BY SINGLE-USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DUODENOSCOPES MARKET SIZE, BY DIRECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DUODENOSCOPES MARKET SIZE, BY DIRECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DUODENOSCOPES MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DUODENOSCOPES MARKET SIZE, BY INDIRECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DUODENOSCOPES MARKET SIZE, BY INDIRECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DUODENOSCOPES MARKET SIZE, BY INDIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DUODENOSCOPES MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DUODENOSCOPES MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DUODENOSCOPES MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DUODENOSCOPES MARKET SIZE, BY RETAILER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DUODENOSCOPES MARKET SIZE, BY RETAILER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DUODENOSCOPES MARKET SIZE, BY RETAILER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DUODENOSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DUODENOSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DUODENOSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DUODENOSCOPES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DUODENOSCOPES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DUODENOSCOPES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DUODENOSCOPES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DUODENOSCOPES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DUODENOSCOPES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DUODENOSCOPES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DUODENOSCOPES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DUODENOSCOPES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DUODENOSCOPES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DUODENOSCOPES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DUODENOSCOPES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DUODENOSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS DUODENOSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA DUODENOSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DUODENOSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. GCC DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GCC DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. GCC DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 115. GCC DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GCC DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 117. GCC DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. GCC DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. G7 DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. G7 DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. G7 DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 136. G7 DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. G7 DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 138. G7 DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. G7 DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. NATO DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. NATO DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 143. NATO DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. NATO DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 145. NATO DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. NATO DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES DUODENOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA DUODENOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. CHINA DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 158. CHINA DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. CHINA DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)